Life Science Leader Magazine Supplements

CMO 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/792774

Contents of this Issue

Navigation

Page 53 of 81

CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 52 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production SERVICES & CAPABILITIES: controlled sub- stances, cytotoxic & high potency compounds, generics, branded APIs, custom development & manufacture "I am extremely proud that Cambrex has for the third consecutive year been selected as a winner of the CMO Leadership Awards. Cambrex has a strong customer focus and a commitment to world class quality. Receiving the awards in the key categories demonstrates our continued com- mitment to our customers and recognition by the pharmaceutical industry." DRUG TYPE: Pharmaceuticals STEVEN M. KLOSK President & CEO CATEGORIES WON: Cambrex East Rutherford, NJ www.cambrex.com Phone: +1 201 804 3000 Contact: Alex Maw Email: alex.maw@cambrex.com Key locations: Charles City, IA, USA; High Point, NC, USA; Karlskoga, Sweden; Paullo, Milan, Italy; Tallinn, Estonia; Wiesbaden, Germany INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: capsules, controlled substances, cytotoxic & high potency compounds, generics, liquids, OTC, peptides, powders: non- sterile, proteins, semisolids, soft gels, solid dose, solutions & suspensions, sustained release, vac- cines "Capsugel is greatly appreciative of this recogni- tion by our customers. Our colleagues through- out the organization strive to provide integrated solutions to advance products from design and development through to commercial manufacture. Our focus is on creating novel, high-quality and customized solutions that align with our custom- ers' evolving needs. We believe our unique com- bination of science, engineering, formulation, and capsule expertise is what sets us apart." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals GUIDO DRIESEN President & CEO CATEGORIES WON: Capsugel Morristown, NJ www.capsugel.com Phone: +1 862 242 1700 Email: dfsinquiry@capsugel.com Key locations: USA, Mexico, Scotland, France, Belgium, India, China, Japan, Indonesia INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, on-time "For the fourth year in a row, Life Science Leader magazine has awarded CEPiA-Sanofi as a worldwide CMO Leader. CEPiA with its industrial European culture has strong assets: 11 chemical sites, manufacturing 200+ API, for more than 60 years. CEPiA serves all pharmaceutical compa- nies, including commercial capacities and specific molecules with exclusive agreements, promoting its Quality and Regulatory worldwide expertise." JACQUES TAVERNIER Vice President CATEGORIES WON: CEPiA Sanofi Antony, France www.cepia-sanofi.com Phone: + 33 1 41 24 55 39 Contact: Christina Da Cunha Email: christina.da-cunha@sanofi.com Key locations: Elbeuf, Sisteron, Frankfurt, Ujpest, Vertolaye, Aramon INDIVIDUAL ATTRIBUTE AWARDS: cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science DRUG TYPE: Pharmaceuticals, Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 3) Drug Substance Production: Drug Substance Production Formulated Drug Production: Dosage Form Production, Packaging SERVICES & CAPABILITIES: aseptic fill/finish, capsules, cartridges, creams & ointments, cyto- toxic & high potency compounds, gels, generics, injectables, lyophilized products, non-sterile, oph- thalmics, OTC, parenterals: large volume, parenter- als: small volume, peptides, powders (non-sterile), proteins, semisolids, solid dose, sterile, sustained release, syringes: prefilled, topicals, vaccines

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2017